COSA 2015* , ,
Presentations this author is a contributor to:
Efficacy and safety of lenvatinib for the treatment of patients with 131I-refractory differentiated thyroid cancer with and without prior VEGF-targeted therapy (#362)
3:00 PM
Brett Hughes
Posters 2
Effect of age and lenvatinib treatment on overall survival for patients with 131I-refractory differentiated thyroid cancer in SELECT (#363)
3:00 PM
Brett Hughes
Posters 2